EIM
AQST icon

Essex Investment Management’s Aquestive Therapeutics AQST Stock Holding History

Essex Investment Management’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-623,310
Closed -$2.22M – 305
2024
Q4 		$2.22M Sell
623,310
-83,768
-12% -$386K 0.4% 107
2024
Q3 		$3.52M Buy
707,078
+1,894
+0.3% +$7.37K 0.61% 63
2024
Q2 		$1.83M Buy
705,184
+92,235
+15% +$308K 0.34% 113
2024
Q1 		$2.61M Sell
612,949
-233,218
-28% -$776K 0.52% 70
2023
Q4 		$1.71M Buy
+846,167
New +$1.5M 0.34% 114

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

Essex Investment Management's AQST Position: Q1 2025 in Review

Essex Investment Management sold out of Aquestive Therapeutics (AQST) in Q1 2025, closing a stake of 623,310 shares — an estimated $2.22M sold.

Essex Investment Management first reported a position in AQST in Q4 2023 and held it in 5 quarters. The position peaked at $3.52M in Q3 2024. 121 funds tracked by Wall St. Rank hold AQST as of Q1 2025.

  • Essex Investment Management reported no remaining Aquestive Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Essex Investment Management sold 623,310 Aquestive Therapeutics shares in Q1 2025, an estimated $2.22M.
  • Essex Investment Management first reported a position in Aquestive Therapeutics in Q4 2023 and held it in 5 quarters.
  • Essex Investment Management's Aquestive Therapeutics position peaked at $3.52M in Q3 2024.
  • 121 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2025.

Based on Essex Investment Management's 13F filing for Q1 2025, filed 7 May 2025.